Gufic Biosciences Limited — Others, 14-04-2025: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Gufic Biosciences has filed an appeal with the Hon’ble Commissioner of Income Tax (Appeals) regarding an assessment order from March 18, 2025, which disallowed deductions for the Assessment Year 2023-24. The company contests the order, stating they were not given sufficient opportunity to explain their claims. The potential financial implication of this matter could amount to approximately ₹11.88 crore. This development may lead to a cautious sentiment among investors, as it underscores ongoing tax disputes that could impact the company's financial stability going forward.